DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/wbtdf7/2016_italy) has announced the addition of the "2016 Italy Clinical Chemistry and Immunodiagnostic Markets: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report to their offering.
The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.
The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Strategic assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics,
collaborative arrangements and new products in R&D.
Market Segmentation Analysis
- Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.
- Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays by market segment:
Current and Emerging Products
- Analysis of current and emerging clinical chemistry and immunodiagnostic tests.
Review of current instrumentation technologies, and feature comparison
of high-, medium-, and low-volume/POC analyzers.
- Assessment of current and emerging technologies, and their potential market applications.
Comprehensive lists of companies developing or marketing new
technologies and products by test.
- Abbott Laboratories
- Agilent Technologies
- Bayer Healthcare
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- Instrumentation Laboratory
- Kyowa Medex
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Thermo Fisher
For more information visit http://www.researchandmarkets.com/research/wbtdf7/2016_italy